Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities

被引:1070
作者
Braunwald, E
机构
[1] HARVARD UNIV, SCH MED, PARTNERS HLTH CARE SYST, BOSTON, MA USA
[2] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA USA
[3] BRIGHAM & WOMENS HOSP, BOSTON, MA 02115 USA
关键词
D O I
10.1056/NEJM199711063371906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:1360 / 1369
页数:10
相关论文
共 56 条
[11]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[12]  
Burt VL, 1996, HYPERTENSION, V27, P1192
[13]   TRENDS IN THE PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE ADULT US POPULATION - DATA FROM THE HEALTH EXAMINATION SURVEYS, 1960 TO 1991 [J].
BURT, VL ;
CUTLER, JA ;
HIGGINS, M ;
HORAN, MJ ;
LABARTHE, D ;
WHELTON, P ;
BROWN, C ;
ROCCELLA, EJ .
HYPERTENSION, 1995, 26 (01) :60-69
[14]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[15]   Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension [J].
Cusi, D ;
Barlassina, C ;
Azzani, T ;
Casari, G ;
Citterio, L ;
Devoto, M ;
Glorioso, N ;
Lanzani, C ;
Manunta, P ;
Righetti, M ;
Rivera, R ;
Stella, P ;
Troffa, C ;
Zagato, L ;
Bianchi, G .
LANCET, 1997, 349 (9062) :1353-1357
[16]  
DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279
[17]  
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
[18]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[19]   Molecular therapies for vascular diseases [J].
Gibbons, GH ;
Dzau, VJ .
SCIENCE, 1996, 272 (5262) :689-693
[20]  
Graves EJ, 1997, VITAL HLTH STAT, V13